Organoid technology offers unprecedented opportunities for modeling human biology in vitro, accelerating drug discovery, and advancing regenerative medicine. Interest in organoids has been further boosted by a recent NIH policy prioritizing funding for new approach methodologies (NAM) and non-animal/other alternative models (NAT) that complement or replace animal models. Scientists continue to innovate, striving for solutions and discoveries that can help organoid research meet its full potential.
Download this eBook to learn more about:
- The NIH’s new policy prioritizing NAM/NAT
- Standardizing organoid composition and research
- How scientist Lori O’Brien uses organoids to study kidney function and disease